Definium Therapeutics: Board
CommitteesIndependence
Carol A. ValloneChairAudit, CompensationIndependent4 yrNot disclosed
Andreas KrebsDirectorAudit, Nominating and Corporate GovernanceIndependent4 yrNot disclosed
Robert BarrowDirectorNoneNot independent4 yrNot disclosed
Suzanne Bruhn, Ph.D.DirectorCompensation (Chair), Nominating and Corporate GovernanceIndependent3 yrNot disclosed
Roger AdsettDirectorNoneIndependent-1 yrNot disclosed
5 seats

The board of the latest proxy statement.